Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation
Kanqiu Jiang,* Mingjing Shen,* Weihua Xu Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou Shi, Jiangsu Sheng, People’s Republic of China *These authors contributed equally to this work Purpose: In this study, a novel arginine, glycine, a...
Guardado en:
Autores principales: | Jiang K, Shen M, Xu W |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dbb63c5e22f3429ca2ab4669dba9b41f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Self-assembled nanoparticles based on amphiphilic chitosan derivative and arginine for oral curcumin delivery
por: Raja MA, et al.
Publicado: (2016) -
Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides
por: Sun J, et al.
Publicado: (2017) -
Liposomal curcumin and its application in cancer
por: Feng T, et al.
Publicado: (2017) -
Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation
por: Hong SS, et al.
Publicado: (2016) -
Preparation of arginine–glycine–aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization
por: Chang CY, et al.
Publicado: (2016)